Dr. Mimi Kim formerly served as an Appointed NISS Board of Trustees Member and Member of the NISS Corporation by Committee of Presidents of Statistical Societies (COPSS). Dr. Kim’s research focuses on statistical methods for designing and analyzing clinical trials and epidemiologic studies (research of the factors affecting health and illness). Most clinical trials aim to demonstrate superiority of an experimental treatment relative to a standard treatment or placebo. An increasing number of trials, however, seek to show that the effects of two treatments on a particular outcome are equivalent, or that one treatment is not inferior to another. These goals are of interest when the new therapy offers benefits such as reduced cost, toxicity, or invasiveness. Dr. Kim is investigating the effects of non-compliance, outcome misclassification and measurement error on equivalence and non-inferiority trials and developing new approaches for defining the non-inferiority margin. Her research interests also include the development of methods for analyzing multivariate and interval-censored survival data. In addition, she collaborates on studies in cancer, rheumatology, and HIV/AIDS.
Dr. Kim has been head of the Division of Biostatistics since 2003, is Director of the Biostatistics Shared Resource of the Institute of Clinical and Translational Research, and Director of the Center for Quantitative Sciences. She is a Fellow of the American Statistical Association, on the American Statistical Association Council of Chapters Governing Board, and is a member of the Medical and Scientific Advisory Council of the Lupus Foundation of America. She has also served as Chair of the ASA Lifetime Data Science Section, Vice-Chair of the Board of Trustees of the National Institute of Statistical Sciences, President of the Korean International Statistical Society, and on the Medical and Scientific Advisory Council of the Lupus Foundation of America. She has participated on numerous grant review panels for the National Institutes of Health and was a member of the NIH Arthritis, Musculoskeletal and Skin Diseases Clinical Trials Review Committee.
Professional Titles:
- Professor, Department of Epidemiology & Population Health (Biostatistics)
- Harold and Muriel Block Chair in Epidemiology & Population Health
- Division Head, Division of Biostatistics, Department of Epidemiology & Population Health
- Director, Biostatistics, Epidemiology and Research Design Core of the Institute for Clinical and Translational Research
- Director, Quantitative Sciences in Biomedical Research Center
- Associate Director, Block Institute for Clinical and Translational Research